JAK/STAT pathway dysregulation in tumors: A Drosophila perspective

Seminars in Cell and Developmental Biology

Volumn 28, Issue , 2014, Pages 96-103

  Amoyel, Marc ^a   Anderson, Abigail M ^a   Bach, Erika A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinoma; Chinmo; Dome; DPIAS; ESCRT; Hop; Imaginal discs; JAK STAT; Melanotic tumors; Myeloproliferative neoplasms; Notch; PRC1; Ras; Scribbled; Socs36E; Stat92E; T42; Tum l; Upd

Indexed keywords

JANUS KINASE; RAS PROTEIN; STAT PROTEIN; DROSOPHILA PROTEIN; HOPSCOTCH PROTEIN, DROSOPHILA; TRANSCRIPTION FACTOR;

CANCER MODEL; CARCINOGENESIS; DROSOPHILA; EPITHELIUM TUMOR; GENE MUTATION; GENE TARGETING; GENETIC SCREENING; HEMATOPOIETIC CELL; IMAGINAL DISC; LEUKEMIA; MELANOMA; NEOPLASM; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL TRANSFORMATION; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DROSOPHILA; DROSOPHILA PROTEINS; HUMANS; JANUS KINASES; NEOPLASMS; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 84901283763     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.03.023     Document Type: Review

References (101)

1. Lacronique V., Boureux A., Valle V.D., Poirel H., Quang C.T., Mauchauffe M., et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 1997, 278(5341):1309-1312.
2. Jones A.V., Kreil S., Zoi K., Waghorn K., Curtis C., Zhang L., et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005, 106(6):2162-2168.
3. Kralovics R., Passamonti F., Buser A.S., Teo S.S., Tiedt R., Passweg J.R., et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005, 352(17):1779-1790.
4. Levine R.L., Wadleigh M., Cools J., Ebert B.L., Wernig G., Huntly B.J., et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005, 7(4):387-397.
5. Moriggl R., Sexl V., Kenner L., Duntsch C., Stangl K., Gingras S., et al. Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell 2005, 7(1):87-99.
6. Abdel-Wahab O. Genetics of the myeloproliferative neoplasms. Curr Opin Hematol 2011, 18(2):117-123.
7. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., et al. Stat3 as an oncogene. Cell 1999, 98(3):295-303.
8. Darnell J.E. Validating Stat3 in cancer therapy. Nat Med 2005, 11(6):595-596.
9. Arbouzova N.I., Zeidler M.P. JAK/STAT signalling in Drosophila: insights into conserved regulatory and cellular functions. Development 2006, 133(14):2605-2616.
10. Kallio J., Myllymaki H., Gronholm J., Armstrong M., Vanha-aho L.M., Makinen L., et al. Eye transformer is a negative regulator of Drosophila JAK/STAT signaling. FASEB J 2010, 24(11):4467-4479.
11. Makki R., Meister M., Pennetier D., Ubeda J.M., Braun A., Daburon V., et al. A short receptor downregulates JAK/STAT signalling to control the Drosophila cellular immune response. PLoS Biol 2010, 8(8):e1000441.
12. Cohen S.M. Imaginal disc development. 1993, Cold Spring Harbor Press, Cold Spring Harbor, NY.
13. Luo H., Asha H., Kockel L., Parke T., Mlodzik M., Dearolf C.R. The Drosophila Jak kinase hopscotch is required for multiple developmental processes in the eye. Dev Biol 1999, 213(2):432-441.
14. Mukherjee T., Hombria J.C., Zeidler M.P. Opposing roles for Drosophila JAK/STAT signalling during cellular proliferation. Oncogene 2005, 24(15):2503-2511.
15. Ekas L.A., Baeg G.H., Flaherty M.S., Ayala-Camargo A., Bach E.A. JAK/STAT signaling promotes regional specification by negatively regulating wingless expression in Drosophila. Development 2006, 133(23):4721-4729.
16. Rodrigues A.B., Zoranovic T., Ayala-Camargo A., Grewal S., Reyes-Robles T., Krasny M., et al. Activated STAT regulates growth and induces competitive interactions independently of Myc, Yorkie, Wingless and ribosome biogenesis. Development 2012, 139(21):4051-4061.
17. Bach E.A., Vincent S., Zeidler M.P., Perrimon N. A sensitized genetic screen to identify novel regulators and components of the Drosophila janus kinase/signal transducer and activator of transcription pathway. Genetics 2003, 165(3):1149-1166.
18. Ekas L.A., Cardozo T.J., Flaherty M.S., Mcmillan E.A., Gonsalves F.C., Bach E.A. Characterization of a dominant-active STAT that promotes tumorigenesis in Drosophila. Dev Biol 2010, 344(2):621-636.
19. Tsai Y.C., Sun Y.H. Long-range effect of upd, a ligand for Jak/STAT pathway, on cell cycle in Drosophila eye development. Genesis 2004, 39(2):141-153.
20. Classen A.K., Bunker B.D., Harvey K.F., Vaccari T., Bilder D. A tumor suppressor activity of Drosophila Polycomb genes mediated by JAK-STAT signaling. Nat Genet 2009, 41(10):1150-1155.
21. Chao J.L., Tsai Y.C., Chiu S.J., Sun Y.H. Localized Notch signal acts through eyg and upd to promote global growth in Drosophila eye. Development 2004, 131(16):3839-3847.
22. Reynolds-Kenneally J., Mlodzik M. Notch signaling controls proliferation through cell-autonomous and non-autonomous mechanisms in the Drosophila eye. Dev Biol 2005, 285(1):38-48.
23. Tsai Y.C., Yao J.G., Chen P.H., Posakony J.W., Barolo S., Kim J., et al. Upd/Jak/STAT signaling represses wg transcription to allow initiation of morphogenetic furrow in Drosophila eye development. Dev Biol 2007, 306(2):760-771.
24. Djiane A., Krejci A., Bernard F., Fexova S., Millen K., Bray S.J. Dissecting the mechanisms of Notch induced hyperplasia. Embo J 2013, 32(1):60-71.
25. Gutierrez-Avino F.J., Ferres-Marco D., Dominguez M. The position and function of the Notch-mediated eye growth organizer: the roles of JAK/STAT and four-jointed. EMBO Rep 2009, 10(9):1051-1058.
26. Flaherty M.S., Zavadil J., Ekas L.A., Bach E.A. Genome-wide expression profiling in the Drosophila eye reveals unexpected repression of notch signaling by the JAK/STAT pathway. Dev Dyn 2009, 238(9):2235-2253.
27. Matsumura I., Kitamura T., Wakao H., Tanaka H., Hashimoto K., Albanese C., et al. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. Embo J 1999, 18(5):1367-1377.
28. Mukherjee T., Schaefer U., Zeidler M.P. Identification of Drosophila genes modulating JAK/STAT signal transduction. Genetics 2006, 172(3):1683-1697.
29. Schwartz Y.B., Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet 2007, 8(1):9-22.
30. Beuchle D., Struhl G., Muller J. Polycomb group proteins and heritable silencing of Drosophila Hox genes. Development 2001, 128(6):993-1004.
31. Oktaba K., Gutierrez L., Gagneur J., Girardot C., Sengupta A.K., Furlong E.E., et al. Dynamic regulation by polycomb group protein complexes controls pattern formation and the cell cycle in Drosophila. Dev Cell 2008, 15(6):877-889.
32. Mills A.A. Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat Rev Cancer 2010, 10(10):669-682.
33. Gonzalez I., Simon R., Busturia A. The Polyhomeotic protein induces hyperplastic tissue overgrowth through the activation of the JAK/STAT pathway. Cell Cycle 2009, 8(24):4103-4111.
34. Feng S., Huang J., Wang J. Loss of the Polycomb group gene polyhomeotic induces non-autonomous cell overproliferation. EMBO Rep 2011, 12(2):157-163.
35. Vaccari T., Bilder D. At the crossroads of polarity, proliferation and apoptosis: the use of Drosophila to unravel the multifaceted role of endocytosis in tumor suppression. Mol Oncol 2009, 3(4):354-365.
36. Rusten T.E., Vaccari T., Stenmark H. Shaping development with ESCRTs. Nat Cell Biol 2012, 14(1):38-45.
37. Lu H., Bilder D. Endocytic control of epithelial polarity and proliferation in Drosophila. Nat Cell Biol 2005, 7(12):1132-1139.
38. Moberg K.H., Schelble S., Burdick S.K., Hariharan I.K. Mutations in erupted, the Drosophila ortholog of mammalian tumor susceptibility gene 101, elicit non-cell-autonomous overgrowth. Dev Cell 2005, 9(5):699-710.
39. Thompson B.J., Mathieu J., Sung H.H., Loeser E., Rorth P., Cohen S.M. Tumor suppressor properties of the ESCRT-II complex component Vps25 in Drosophila. Dev Cell 2005, 9(5):711-720.
40. Vaccari T., Bilder D. The Drosophila tumor suppressor vps25 prevents nonautonomous overproliferation by regulating notch trafficking. Dev Cell 2005, 9(5):687-698.
41. Herz H.M., Chen Z., Scherr H., Lackey M., Bolduc C., Bergmann A. vps25 mosaics display non-autonomous cell survival and overgrowth, and autonomous apoptosis. Development 2006, 133(10):1871-1880.
42. Menut L., Vaccari T., Dionne H., Hill J., Wu G., Bilder D. A mosaic genetic screen for Drosophila neoplastic tumor suppressor genes based on defective pupation. Genetics 2007, 177(3):1667-1677.
43. Morrison H.A., Dionne H., Rusten T.E., Brech A., Fisher W.W., Pfeiffer B.D., et al. Regulation of early endosomal entry by the Drosophila tumor suppressors Rabenosyn and Vps45. Mol Biol Cell 2008, 19(10):4167-4176.
44. Herz H.M., Bergmann A. Genetic analysis of ESCRT function in Drosophila: a tumour model for human Tsg101. Biochem Soc Trans 2009, 37(Pt 1):204-207.
45. Vaccari T., Rusten T.E., Menut L., Nezis I.P., Brech A., Stenmark H., et al. Comparative analysis of ESCRT-I, ESCRT-II and ESCRT-III function in Drosophila by efficient isolation of ESCRT mutants. J Cell Sci 2009, 122(Pt 14):2413-2423.
46. Woodfield S.E., Graves H.K., Hernandez J.A., Bergmann A. De-regulation of JNK and JAK/STAT signaling in ESCRT-II mutant tissues cooperatively contributes to neoplastic tumorigenesis. PLoS ONE 2013, 8(2):e56021.
47. Vaccari T., Lu H., Kanwar R., Fortini M.E., Bilder D. Endosomal entry regulates Notch receptor activation in Drosophila melanogaster. J Cell Biol 2008, 180(4):755-762.
48. Rodahl L.M., Haglund K., Sem-Jacobsen C., Wendler F., Vincent J.P., Lindmo K., et al. Disruption of Vps4 and JNK function in Drosophila causes tumour growth. PLoS ONE 2009, 4(2):e4354.
49. Thomas C., Strutt D. Rabaptin-5 and Rabex-5 are neoplastic tumour suppressor genes that interact to modulate Rab5 dynamics in Drosophila melanogaster. Dev Biol 2014, 385(1):107-121.
50. Gilbert M.M., Beam C.K., Robinson B.S., Moberg K.H. Genetic interactions between the Drosophila tumor suppressor gene ept and the stat92E transcription factor. PLoS ONE 2009, 4(9):e7083.
51. Devergne O., Ghiglione C., Noselli S. The endocytic control of JAK/STAT signalling in Drosophila. J Cell Sci 2007, 120(Pt 19):3457-3464.
52. Vidal O.M., Stec W., Bausek N., Smythe E., Zeidler M.P. Negative regulation of Drosophila JAK-STAT signalling by endocytic trafficking. J Cell Sci 2010, 123(Pt 20):3457-3466.
53. Lovegrove B., Simoes S., Rivas M.L., Sotillos S., Johnson K., Knust E., et al. Coordinated control of cell adhesion, polarity, and cytoskeleton underlies Hox-induced organogenesis in Drosophila. Curr Biol 2006, 16(22):2206-2216.
54. Bilder D. Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev 2004, 18(16):1909-1925.
55. Bilder D., Perrimon N. Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature 2000, 403(6770):676-680.
56. Bilder D., Li M., Perrimon N. Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science 2000, 289(5476):113-116.
57. Brumby A.M., Richardson H.E. scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. Embo J 2003, 22(21):5769-5779.
58. Igaki T., Pagliarini R.A., Xu T. Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol 2006, 16(11):1139-1146.
59. Pagliarini R.A., Xu T. A genetic screen in Drosophila for metastatic behavior. Science 2003, 302(5648):1227-1231.
60. Pastor-Pareja J.C., Wu M., Xu T. An innate immune response of blood cells to tumors and tissue damage in Drosophila. Dis Model Mech 2008, 1(2-3):144-154. [discussion 153].
61. Wu M., Pastor-Pareja J.C., Xu T. Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion. Nature 2010, 463(7280):545-548.
62. Herranz H., Hong X., Hung N.T., Voorhoeve P.M., Cohen S.M. Oncogenic cooperation between SOCS family proteins and EGFR identified using a Drosophila epithelial transformation model. Genes Dev 2012, 26(14):1602-1611.
63. Corwin H.O., Hanratty W.P. Characterization of a unique lethal tumorous mutation in Drosophila. Mol Gen Genet 1976, 144(3):345-347.
64. Hanratty W.P., Ryerse J.S. A genetic melanotic neoplasm of Drosophila melanogaster. Dev Biol 1981, 83(2):238-249.
65. Evans C.J., Hartenstein V., Banerjee U. Thicker than blood: conserved mechanisms in Drosophila and vertebrate hematopoiesis. Dev Cell 2003, 5(5):673-690.
66. Jung S.H., Evans C.J., Uemura C., Banerjee U. The Drosophila lymph gland as a developmental model of hematopoiesis. Development 2005, 132(11):2521-2533.
67. Sorrentino R.P., Carton Y., Govind S. Cellular immune response to parasite infection in the Drosophila lymph gland is developmentally regulated. Dev Biol 2002, 243(1):65-80.
68. Krzemien J., Dubois L., Makki R., Meister M., Vincent A., Crozatier M. Control of blood cell homeostasis in Drosophila larvae by the posterior signalling centre. Nature 2007, 446(7133):325-328.
69. Minakhina S., Steward R. Hematopoietic stem cells in Drosophila. Development 2010, 137(1):27-31.
70. Mondal B.C., Mukherjee T., Mandal L., Evans C.J., Sinenko S.A., Martinez-Agosto J.A., et al. Interaction between differentiating cell- and niche-derived signals in hematopoietic progenitor maintenance. Cell 2011, 147(7):1589-1600.
71. Sorrentino R.P., Tokusumi T., Schulz R.A. The Friend of GATA protein U-shaped functions as a hematopoietic tumor suppressor in Drosophila. Dev Biol 2007, 311(2):311-323.
72. Gao H., Wu X., Fossett N. Upregulation of the Drosophila Friend of GATA gene U-shaped by JAK/STAT signaling maintains lymph gland prohemocyte potency. Mol Cell Biol 2009, 29(22):6086-6096.
73. Minakhina S., Tan W., Steward R. JAK/STAT and the GATA factor Pannier control hemocyte maturation and differentiation in Drosophila. Dev Biol 2011, 352(2):308-316.
74. Hanratty W.P., Dearolf C.R. The Drosophila Tumorous-lethal hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol Gen Genet 1993, 238(1-2):33-37.
75. Lanot R., Zachary D., Holder F., Meister M. Postembryonic hematopoiesis in Drosophila. Dev Biol 2001, 230(2):243-257.
76. Minakhina S., Steward R. Melanotic mutants in Drosophila: pathways and phenotypes. Genetics 2006, 174(1):253-263.
77. Luo H., Rose P., Barber D., Hanratty W.P., Lee S., Roberts T.M., et al. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol 1997, 17(3):1562-1571.
78. Harrison D.A., Binari R., Nahreini T.S., Gilman M., Perrimon N. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. Embo J 1995, 14(12):2857-2865.
79. Luo H., Hanratty W.P., Dearolf C.R. An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects. Embo J 1995, 14(7):1412-1420.
80. Ungureanu D., Wu J., Pekkala T., Niranjan Y., Young C., Jensen O.N., et al. The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling. Nat Struct Mol Biol 2011, 18(9):971-976.
81. Bandaranayake R.M., Ungureanu D., Shan Y., Shaw D.E., Silvennoinen O., Hubbard S.R. Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F. Nat Struct Mol Biol 2012, 19(8):754-759.
82. Hou X.S., Melnick M.B., Perrimon N. Marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell 1996, 84(3):411-419.
83. Yan R., Small S., Desplan C., Dearolf C.R., Darnell J.E. Identification of a Stat gene that functions in Drosophila development. Cell 1996, 84(3):421-430.
84. Silvers M., Hanratty W.P. Alterations in the production of hemocytes due to a neoplastic mutation of Drosophila melanogaster. J Invertebr Pathol 1984, 44(3):324-328.
85. Zettervall C.J., Anderl I., Williams M.J., Palmer R., Kurucz E., Ando I., et al. A directed screen for genes involved in Drosophila blood cell activation. Proc Natl Acad Sci U S A 2004, 101(39):14192-14197.
86. Hari K.L., Cook K.R., Karpen G.H. The Drosophila Su(var)2-10 locus regulates chromosome structure and function and encodes a member of the PIAS protein family. Genes Dev 2001, 15(11):1334-1348.
87. Betz A., Lampen N., Martinek S., Young M.W., Darnell J.E. A Drosophila PIAS homologue negatively regulates stat92E. Proc Natl Acad Sci U S A 2001, 98(17):9563-9568.
88. Baeg G.H., Zhou R., Perrimon N. Genome-wide RNAi analysis of JAK/STAT signaling components in Drosophila. Genes Dev 2005, 19(16):1861-1870.
89. Muller P., Kuttenkeuler D., Gesellchen V., Zeidler M.P., Boutros M. Identification of JAK/STAT signalling components by genome-wide RNA interference. Nature 2005, 436(7052):871-875.
90. Badenhorst P., Voas M., Rebay I., Wu C. Biological functions of the ISWI chromatin remodeling complex NURF. Genes Dev 2002, 16(24):3186-3198.
91. Kwon S.Y., Xiao H., Glover B.P., Tjian R., Wu C., Badenhorst P. The nucleosome remodeling factor (NURF) regulates genes involved in Drosophila innate immunity. Dev Biol 2008, 316(2):538-547.
92. Arbouzova N.I., Bach E.A., Zeidler M.P. Ken & barbie selectively regulates the expression of a subset of Jak/STAT pathway target genes. Curr Biol 2006, 16(1):80-88.
93. Kugler S.J., Gehring E.M., Wallkamm V., Kruger V., Nagel A.C. The Putzig-NURF nucleosome remodeling complex is required for ecdysone receptor signaling and innate immunity in Drosophila melanogaster. Genetics 2011, 188(1):127-139.
94. Shi S., Calhoun H.C., Xia F., Li J., Le L., Li W.X. JAK signaling globally counteracts heterochromatic gene silencing. Nat Genet 2006, 38(9):1071-1076.
95. Shi S., Larson K., Guo D., Lim S.J., Dutta P., Yan S.J., et al. Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability. Nat Cell Biol 2008, 10(4):489-496.
96. Myrick K.V., Dearolf C.R. Hyperactivation of the Drosophila Hop jak kinase causes the preferential overexpression of eIF1A transcripts in larval blood cells. Gene 2000, 244(1-2):119-125.
97. Flaherty M.S., Salis P., Evans C.J., Ekas L.A., Marouf A., Zavadil J., et al. chinmo is a functional effector of the JAK/STAT pathway that regulates eye development, tumor formation and stem cell self-renewal in Drosophila. Dev Cell 2010, 18(4):556-568.
98. Bina S., Wright V.M., Fisher K.H., Milo M., Zeidler M.P. Transcriptional targets of Drosophila JAK/STAT pathway signalling as effectors of haematopoietic tumour formation. EMBO Rep 2010, 11(3):201-207.
99. Bausek N., Zeidler M.P. Galpha73B is a downstream effector of JAK/STAT signalling and a regulator of Rho1 in Drosophila haematopoiesis. J Cell Sci 2014, 127(Pt 1):101-110.
100. Read R.D., Bach E.A., Cagan R.L. Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways. Mol Cell Biol 2004, 24(15):6676-6689.
101. Corcoran R.B., Contino G., Deshpande V., Tzatsos A., Conrad C., Benes C.H., et al. STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis. Cancer Res 2011, 71(14):5020-5029.